Advertisement
Advertisement
Trending on Urology Times
1
Alan Bryce, MD, highlights key phase 3 advances in prostate cancer
2
FDA clears Revi Extend implant for urgency urinary incontinence
3
Trial to evaluate ivonescimab plus enfortumab vedotin in urothelial carcinoma
4
Pearls & Perspectives: Wearable Technology and the Future of Sexual Health, With Elliot Justin, MD
5